Czechia· CZ-0026354
ALDURAZYME
A laronidase product containing laronidase, registered in Czechia by Sanofi B.V., Amsterdam. The same ATC class is registered in 12 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Laronidase is registered in 12 of 19 countries.
Countries holding a registration under ATC A16AB05 (laronidase), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Laronidase · ATC A16AB05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- LARONIDASE
- Manufacturer
- Sanofi B.V., Amsterdam
- Country
- Czechia (CZ)
- ATC code
- A16AB05
- ATC class
- Laronidase
- Defined daily dose
- 1 TSD, E
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl00263541X5MLCZK 17413.06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for laronidase.
Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Laronidase · interactions on record
2 records
Same medicine, other countries
Laronidase in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAldurazymeSanofi B.V.
- United StatesALDURAZYMEGenzyme Corporation
- FranceALDURAZYME 100 U/ml, solution à diluer pour perfusionSANOFI (PAYS-BAS)
- United KingdomAldurazyme 500units/5ml concentrate for solution for infusion vialsSanofi
- BelgiumAldurazyme 100 U/mlSanofi
- IcelandAldurazymeGenzyme Europe B.V.
- Japanラロニダーゼ（遺伝子組換え）サノフィ
- NetherlandsAldurazyme, concentraat voor oplossing voor i.v. infusie, 100U/ml, 5 mlGenzyme Europe BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aldurazyme
- Liechtenstein · Aldurazyme
- Norway · Aldurazyme
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c37eb195-80d5-4ef7-81bf-d64d0694cdf0 GET /v1/drugs/c37eb195-80d5-4ef7-81bf-d64d0694cdf0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INF CNC SOL",
"source": "sukl",
"strength": "100U/ML",
"pack_size": "1X5ML",
"substance": "LARONIDASE",
"cz_kod_sukl": "0026354",
"product_type": "BT",
"substance_codes": "16504",
"registration_state": "R",
"registration_number": "EU/1/03/253/001"
}See everything about laronidase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.